Wyeth Packaging Problems Lead To Warning Letter, Triphasil-28 Recall

Wyeth failed to adequately investigate cases of contamination involving a packaging extractable for two oral contraceptive drugs manufactured at the firm's Guayama, Puerto Rico facility, FDA states in a recent warning letter